Brain Scientific Inc.
BRSF
$0.75
-$0.35-31.82%
| 12/31/2022 | 09/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -55.26% | -70.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -55.26% | -70.39% | |||
| Cost of Revenue | 180.49% | -89.21% | |||
| Gross Profit | -187.84% | 1,380.00% | |||
| SG&A Expenses | -64.24% | 88.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -62.57% | 80.63% | |||
| Operating Income | 62.59% | -83.28% | |||
| Income Before Tax | 27.12% | -76.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 27.12% | -76.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.12% | -76.50% | |||
| EBIT | 62.59% | -83.28% | |||
| EBITDA | 66.44% | -91.70% | |||
| EPS Basic | 27.92% | -2.33% | |||
| Normalized Basic EPS | 43.79% | -2.32% | |||
| EPS Diluted | 27.92% | -2.33% | |||
| Normalized Diluted EPS | 43.79% | -2.32% | |||
| Average Basic Shares Outstanding | 1.10% | 72.49% | |||
| Average Diluted Shares Outstanding | 1.10% | 72.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
